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ABSTRACT  
To detect and characterise different phenotypes of respiratory disease in children and young 
adults with sickle cell disease (SCD), eleven lung function and haematological biomarkers 
were analysed using k-means cluster analysis in a cohort of 114 SCD subjects aged 
between 5 and 27years.  Three clusters were detected:  cluster one had elevated pulmonary 
capillary blood volume, mixed obstructive/restrictive lung disease, hypoxia and moderately 
severe anaemia; cluster two were older patients with restrictive lung disease; cluster three 
were younger patients with obstructive lung disease, elevated serum lactate dehydrogenase 
and bronchodilator reversibility. These results may inform more personalised management 
strategies to improve outcomes.  
 
 
 
3 
 
INTRODUCTION 
Sickle cell disease (SCD) is one of the commonest inherited disorders worldwide, affecting 
an estimated 300,000 new-borns every year.  The majority of SCD children in developed 
countries will survive to adulthood, but may then suffer multiorgan damage, including 
pulmonary complications. Whilst lung function abnormalities are common in both children 
and adults, there is not a consistent picture. Furthermore, the aetiology and clinical 
consequences of the lung function abnormalities are unclear.  It seems likely that the 
respiratory disease is not homogenous [1]. Identification of different phenotypes of 
respiratory disease may provide a basis to stratify patients with regard to management.  
Cluster analysis is a method of detecting subgroups within multidimensional (i.e. comprising 
many and/or varied measurements) datasets.[2] We hypothesised that cluster analysis of 
respiratory function and haematological biomarkers would reveal different phenotypes in 
patients with SCD.  
 
METHODS 
Study design 
A secondary analysis of data from children and young adults with sickle cell anaemia (SCA) 
(homozygous for sickle cell haemoglobin (HbSS)) and ages ranging from 5 to 27 years was 
conducted.[3-5] The studies were approved by King’s College Hospital Research Ethics 
Committee and participants or their parents (in the case of children) gave informed written 
consent to take part. 
 
Lung function measurements (see online supplement) 
Respiratory system resistance at a frequency of 5Hz (Rrs5) was measured, then   
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spirometry (FEV1:VC), static lung volumes using whole-body plethysmography (TLC) and 
gas transfer for carbon monoxide (DLCO) were assessed according to American Thoracic 
Society/European Thoracic Society criteria.[6-8]  The transfer factor for nitric oxide (DLNO) 
was obtained by the addition of 40ppm NO to the inspired gas mixture prior to commencing 
the single-breath DLCO measurement and used to estimate the pulmonary capillary blood 
volume (PCBV).[3]  Arterial oxygen saturation (SpO2) was measured using pulse oximetry 
(Masimo Radical 7, Masimo, CA).  
 
Haematological data and SCD complications 
The haemoglobin concentrations (Hb), lactate dehydrogenase (LDH) levels, reticulocyte 
percentage (reticulocyte%) and white cell counts (WCC) were obtained from routine blood 
tests undertaken within three months of lung function testing. The medical records were 
reviewed and an ACS episode was diagnosed if the child had suffered chest pain, dyspnoea 
and pyrexia together with a new pulmonary infiltrate on chest radiograph. To determine the 
impact of cluster membership on future morbidity, the medical records were reviewed for the 
period subsequent to the lung function testing and the occurrence of individual ACS 
episodes and non-elective hospital admissions were recorded and expressed as 
events/year. 
 
Statistical analysis 
Variables included in the cluster analysis were FEV1:VC, TLC, Rrs5, DLCO, PCBV, [Hb], 
SpO2, LDH, WCC, reticulocyte% and age at time of testing. The number of clusters was 
selected using the CritCF index [9] which ranks partitions comprising different numbers of 
clusters; a higher CritCF indicates a better clustering 
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RESULTS 
Data from 114 patients with complete lung function results and a median age 14.5 (5.0-27.1) 
years were analysed (see online supplement Table A).  A three-cluster solution was found to 
be optimal (see online supplement Figure S1).  The clustering solution was robust under 
multiple imputations with the same three-cluster partition occurring in 96.4% of imputed 
datasets (see online supplement Figure S1). For all lung function and haematological 
variables, the proportion of patients with obstructive, restrictive or mixed lung function 
defects and the prevalence of bronchodilator reversibility, but not the proportion taking 
hydroxyurea, receiving regular transfusions or with a history of ACS episodes, differed 
significantly between clusters (Table 1).  Clusters were well separated, with little overlap on 
a discriminant coordinates plot (see online supplement Figure S2).  Physiological profiles for 
the three clusters are shown graphically (see online supplement Figure S3).   
 
Cluster one had the largest proportion with mixed obstructive/restrictive lung disease and 
both the highest respiratory system resistance and pulmonary capillary blood volume. 
Cluster two comprised older patients with the highest FEV1:VC ratio and a low TLC (i.e. 
restrictive pattern), the lowest gas transfer gas transfer, but highest haemoglobin. Cluster 
three comprised younger patients with the highest incidence of bronchodilator reversibility 
and the highest LDH levels (Table 1).  Cluster three has a greater frequency of hospital 
admissions for vaso-occlusive crises, but not ACS episodes, than clusters one and two (both 
p<0.05) see on line supplement.  
 
A conditional inference tree analysis was performed on the subset of patients assigned to 
the training set (n=85).  A model using three variables (PCBV, DLCO and LDH) (Figure 1) 
was found to be optimal and assigned 90% of patients from the unseen validation set to the 
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correct cluster.  Classification success rates for clusters one, two and three were 80%, 93% 
and 90%, respectively.   
 
DISCUSSION 
Analysis of lung function and haematological data detected three distinct clusters in children 
and young adults with SCD.  Cluster one had the highest respiratory system resistance and 
pulmonary capillary blood volume which suggest they may have peripheral airways disease 
mediated by pulmonary vascular engorgement. We speculate that this interaction may arise 
from direct compression of distal airways by adjacent pulmonary vessels within peribronchial 
sheaths or from bronchovascular congestion due to elevated pulmonary venous pressure. 
Haemoglobin levels were significantly higher in cluster two which suggests that their 
restrictive lung disease might be related to increased blood viscosity leading to impaired 
microvascular blood flow and an increased likelihood of occult vaso-occlusion in the 
pulmonary capillary plexus with consequent cumulative lung injury.  Cluster three had the 
highest LDH levels and the highest incidence of bronchodilator reversibility. Those findings 
are consistent with the observation that airway hyper-reactivity, as assessed by 
methacholine challenge testing, was associated with elevated LDH levels.[10] Serum LDH, 
but not reticulocyte count or haemoglobin concentration was discriminative for cluster three.  
This may reflect LDH had a greater sensitivity as a marker of haemolysis. LDH, however, is 
thought to primarily reflect intravascular haemolysis, thus in cluster three compared to the 
other two clusters perhaps a greater proportion of overall haemolytic activity was occurring in 
the intravascular compartment.   
Conditional tree analysis demonstrated that a subset of the variables could reliably predict 
cluster membership.  This suggests that a method for phenotyping of SCD respiratory 
subclasses could be based on those biomarkers.
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 Table 1 Subject characteristics by cluster.   
*Lung function tests are expressed as the percentage predicted for age and/or height. 
†Supplementary data not used in the clustering. 
 Cluster 1 (n = 14) Cluster 2 (n = 55) Cluster 3 (n = 45) p 
FEV1:VC * 92.4 (88.05 – 
100.9) 
97.3 (91.1 – 102.6)  90.7 (85.9 – 96.2) 0.002 
Rrs5* 165.8 (140.8 -
186.5) 
131.6 (112.9 – 
160.3) 
133.4 (110.2 – 
153.6) 
0.020 
TLC* 84.8 (82.2 – 86.8) 85.6 (77.4 – 91.6) 94.1 (85.7 – 99.6) 0.003 
DLCO* 98.1 (92.5 – 106.2) 77.8 (72.2 – 83.8) 96.6 (88.9 – 108.3) <0.0001 
PCBV (ml/L) 44.9 (41.4 – 47.0) 21.1 (17.9 – 23.5)  26.4 (23.4 – 29.7) <0.0001 
[Hb] (g/dl) 8.2 (7.4 – 8.9) 9.9 (8.7 – 10.8) 8.4 (5.7 – 9.2) <0.0001 
SpO2 (%)  95.8 (95.0 – 97.8) 97.0 (95.8 – 99.0) 95.5 (93.0 – 98.0) 0.0327 
LDH (IU/L) 495 (441 - 622) 399.5 (303.5 – 
474.8) 
639 (542 – 732.0) <0.0001 
WCC (x109/L) 10.7 (10.3 – 12.4) 9.2 (7.3 – 10.8) 11.0 (8.8 – 12.3) 0.015 
Reticulocyte 
%   
12.7 (10.6 – 14.2) 8.5 (6.5 – 10.5) 10.4 (7.7 – 12.8) 0.018 
Age (yrs) 14.2 (10.3 – 17.0) 17.5 (13.3 – 21.6) 11.3 (9.0 – 14.5) <0.0001 
% 
Obstructive† 
0% 9.1% 26.7% 0.027 
% 
Restrictive† 
14% 29.1% 4.4% 0.023 
% Mixed† 21% 5.5% 4.4% 0.028 
ACS ever† 35.7% 33.3% 33.3% 0.9231 
BDR %† 7.1% 2.0% 15.6% 0.0338 
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% 
Hydroxyurea 
14.3% 10.9% 15.6% 0.7358 
% 
Transfusion 
7.1% 20.0% 31.1% 0.1633 
 
† BDR: bronchodilator reversibility. 
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FIGURE LEGENDS 
Figure 1:  Stratification algorithm to predict cluster membership 
 
 
